Ali Muhammad, MD MBA PhD - Beverly ...

Dr. Ali Muhammad, MD, MBA

Claim this profile

Beverly Hills Cancer Center

Studies Lung Cancer
Studies Colorectal Cancer
7 reported clinical trials
17 drugs studied

Area of expertise

1

Lung Cancer

Ali Muhammad, MD, MBA has run 3 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Progression
Metastatic
2

Colorectal Cancer

Ali Muhammad, MD, MBA has run 2 trials for Colorectal Cancer.

Affiliated Hospitals

Image of trial facility.

Beverly Hills Cancer Center

Image of trial facility.

Beverly Hills Cancer Center & Optima Diagnostic Imaging-Site Number:8400007

Clinical Trials Ali Muhammad, MD, MBA is currently running

Image of trial facility.

Combination Therapy

for Multiple Myeloma

The main purpose of the study is to evaluate the safety and tolerability of the combination of elranatamab and carfilzomib and dexamethasone or elranatamab and maplirpacept. There are 2 parts to this study. Part 1 will evaluate the safety and tolerability of elranatamab when given in combination with carfilzomib plus dexamethasone. Part 2 has 2 arms. The first will evaluate the safety and tolerability of elranatamab when given in combination with maplirpacept. The second will identify the optimal dose(s) of elranatamab plus maplirpacept. All study medicines are given over 4-week cycles. Everyone taking part in this study will receive elranatamab as a shot under the skin. Participants in Part 1 will also receive weekly carfilzomib as an IV infusion (given directly into a vein) and dexamethasone either by mouth (as a pill) or by IV infusion. Participants in Part 2 will receive elranatamab in combination with maplirpacept as an IV infusion (given directly into a vein) The investigators will examine the experiences of people receiving the study medicines. This will help determine if the study medicines are safe and can be used for multiple myeloma treatment. Participants will take part in this study for about 2 years after the first dose.

Recruiting

1 award

Phase 1

11 criteria

Image of trial facility.

Immunotherapy + Radiotherapy

for Non-Small Cell Lung Cancer

This trial is testing a new treatment for advanced lung cancer using special immune cells from healthy donors and a small amount of radiation. The goal is to see if this combination is safe and effective. The immune cells help the body fight cancer, and the radiation makes the cancer cells easier to attack.

Recruiting

1 award

Phase 1

10 criteria

More about Ali Muhammad, MD, MBA

Clinical Trial Related

3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Ali Muhammad, MD, MBA has experience with

  • NovoTTF-200T
  • NovoTTF-100L
  • Trilaciclib
  • Ponsegromab
  • Placebo For Ponsegromab
  • Capecitabine

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Ali Muhammad, MD, MBA specialize in?

Is Ali Muhammad, MD, MBA currently recruiting for clinical trials?

Are there any treatments that Ali Muhammad, MD, MBA has studied deeply?

What is the best way to schedule an appointment with Ali Muhammad, MD, MBA?

What is the office address of Ali Muhammad, MD, MBA?

Is there any support for travel costs?